Join or Renew ISV Membership Today!
www.isv-online.org
Join or Renew ISV Membership Today!
www.isv-online.org
zoom.us/j/95023027392
zoom.us/j/95023027392
7 FEBRUARY 2025
”Early Career Researcher session: Longitudinal Assessment of Human Immune Responses to Commercial Influenza Vaccination”.
Dr. James Allen, PhD, Cleveland Clinic, USA.
1/2
7 FEBRUARY 2025
”Early Career Researcher session: Longitudinal Assessment of Human Immune Responses to Commercial Influenza Vaccination”.
Dr. James Allen, PhD, Cleveland Clinic, USA.
1/2
JANUARY WEBINAR
22 JANUARY 2025 11:00 (EST) Title: Development of Nirsevimab:
A Monoclonal Antibody for the Prevention of RSV Disease in Infants
Dr. Tonya Villafana Astra Zeneca
Join Zoom Webinar: lnkd.in/d7q2eeRp
JANUARY WEBINAR
22 JANUARY 2025 11:00 (EST) Title: Development of Nirsevimab:
A Monoclonal Antibody for the Prevention of RSV Disease in Infants
Dr. Tonya Villafana Astra Zeneca
Join Zoom Webinar: lnkd.in/d7q2eeRp
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Zhang et al. Genome Med. 2024 Nov 14;16(1):131. doi: 10.1186/s13073-024-01388-3.
lnkd.in/d5VaHPqc
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Zhang et al. Genome Med. 2024 Nov 14;16(1):131. doi: 10.1186/s13073-024-01388-3.
lnkd.in/d5VaHPqc
To get involved, please email to nextgenvacc@gmail.com, or visit lnkd.in/dAbCzDBS.
To get involved, please email to nextgenvacc@gmail.com, or visit lnkd.in/dAbCzDBS.
November 2024!!
November 2024!!